ampelopsin has been researched along with Disease Models, Animal in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.33) | 29.6817 |
2010's | 20 (66.67) | 24.3611 |
2020's | 9 (30.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
He, X; Li, Y; Liu, D; Liu, T; Lv, W; Wang, Y | 1 |
Liu, DY; Zheng, HQ | 1 |
Chen, X; Huo, Y; Li, H; Liu, Y; Ma, W; Shi, P; Tian, X; Wang, H; Xie, L; Zhang, J | 1 |
Chen, M; Feng, L; Li, Z; Ou, C; Que, D; Wei, J; Yan, J; Yang, P; Zhang, X; Zhong, X | 1 |
Cai, G; Hou, L; Hu, CY; Huang, B; Jiang, F; Jiang, Y; Liu, D; Wang, C; Zheng, W | 1 |
Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Upadhyay, D; Wasan, H | 1 |
Chen, J; Hu, Y; Li, Y; Qi, K; Wang, R; Wei, Y | 1 |
Bai, X; Guo, L; Luo, Q; Tan, K | 1 |
Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT | 1 |
Li, BR; Wang, L; Xiao, ZY; Yu, XD; Zhao, JL | 1 |
Fang, S; Huang, S; Wang, C; Xu, B; Zhang, H; Zhang, Y | 1 |
Chen, X; Liu, TT; Tang, K; Xu, XL; Zeng, Y; Zhang, W | 1 |
Kirby, BP; Ren, Z; Waddington, JL; Yan, P; Yang, H; Zhao, Y; Zhen, X; Zhu, L | 1 |
Li, Q; Wang, J; Wu, X; Xie, J; Xu, Y; Yu, J; Zeng, Z; Zhu, X | 1 |
Bi, H; Chu, J; Li, L; Ren, M; Wang, J; Wang, X | 1 |
Chen, JF; Du, YH; Feng, J; He, GQ; Liu, Y; Liu, YJ; Wang, JX; Wang, KJ; Zhang, W; Zheng, M | 1 |
Han, J; Meng, F; Qu, D; Wang, D; Xu, M; Zhang, X; Zheng, Q | 1 |
Chen, M; Huang, B; Li, Y; Shu, W; Yao, Y | 1 |
Guo, J; Liu, LH; Qu, CH; Sun, P; Wang, CX; Wang, SH; Yin, JB | 1 |
Guo, L; Yan, X; Zhang, H | 1 |
Bi, X; Han, W; He, T; Jiang, W; Li, Y; Liu, C; Liu, Y; Xiao, T; Xiong, J; Xu, X; Yang, K; Yu, Y; Zhang, B; Zhang, J; Zhao, J | 1 |
Bai, XJ; Gao, W; Li, ZF; Liu, QX; Liu, T; Liu, XH; Wang, YC; Xu, XE; Zheng, Q | 1 |
Hui, SC; Kang, C; Lang, HD; Mi, MT; Wang, XL; Yi, L; Zhang, Y; Zhou, M; Zhu, XH | 1 |
Liang, J; Lindemeyer, AK; López-Valdés, HE; Martínez-Coria, H; Olsen, RW; Shao, XM; Shen, Y | 1 |
Chen, TM; Dai, D; Hu, LP; Lan, Q; Liu, B; Liu, J; Xie, J; Zhang, QY; Zhang, WD; Zhu, RZ | 1 |
Jiao, P; Liu, Q; Wang, JT; Zhou, Y | 1 |
Chen, J; Chen, Y; Chi, X; Guo, D; Jiang, Y; Jiang, Z; Lin, J; Lv, L; Pi, H; Qin, W; Yang, H | 1 |
Gonzalez, C; Liang, J; Lindemeyer, AK; Olsen, RW; Shao, XM; Shen, Y; Spigelman, I | 1 |
Chen, LF; Wang, XH; Wang, XQ; Yang, XM | 1 |
30 other study(ies) available for ampelopsin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Ampelopsin Improves Cognitive Impairment in Alzheimer's Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alzheimer Disease; Animals; Cognitive Dysfunction; Cytokines; Dinoprost; Disease Models, Animal; Flavonoids; Hippocampus; Inflammation; Male; Maze Learning; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats | 2020 |
[Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Topics: Animals; Antineoplastic Agents; Cell Movement; Disease Models, Animal; Flavonoids; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
The role of miR-199b-3p in regulating Nrf2 pathway by dihydromyricetin to alleviate septic acute kidney injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Disease Models, Animal; Flavonols; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; MicroRNAs; NF-E2-Related Factor 2; Sepsis | 2021 |
Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling.
Topics: Animals; Aorta; Aortic Diseases; Cells, Cultured; Disease Models, Animal; Flavonols; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification | 2021 |
Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Body Composition; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Line; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Flavonols; Glucose; Inflammation; Male; Mice; Molecular Imaging; Muscle, Skeletal; Muscular Atrophy; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Dihydromyricetin alleviates cerebral ischemia-reperfusion injury by attenuating apoptosis and astrogliosis in peri-infarct cortex.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Flavonols; Gliosis; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury | 2022 |
Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway.
Topics: Animals; Behavior, Animal; Depression; Disease Models, Animal; Flavonols; Hypoxia-Inducible Factor 1, alpha Subunit; Illness Behavior; Lipopolysaccharides; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Proto-Oncogene Proteins c-akt; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy.
Topics: Animals; Autophagy; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Flavonols; MicroRNAs; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Transfection | 2020 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen | 2020 |
[Dihydromyricetin ameliorates chronic social defeat stress induced cognitive and affective disorder in mice].
Topics: Animals; Anxiety; Depression; Disease Models, Animal; Flavonols; Hippocampus; Learning; Memory; Mice; Mice, Inbred C57BL; Mood Disorders; Random Allocation; Sirtuin 1; Stress, Psychological | 2019 |
Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Female; Flavonols; Goblet Cells; Immunoglobulin E; Immunoglobulin G; Mice; Mucus; Ovalbumin | 2017 |
Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Aortic Diseases; Atherosclerosis; Cytokines; Diet, High-Fat; Disease Models, Animal; Flavonols; Foam Cells; Genetic Predisposition to Disease; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Lipoproteins, LDL; Liver; Male; Mice; Mice, Knockout; Oxidative Stress; Phenotype; Plaque, Atherosclerotic; RAW 264.7 Cells; Receptors, LDL | 2017 |
Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Flavonols; Glycogen Synthase Kinase 3 beta; Hindlimb Suspension; Hippocampus; Locomotion; Male; Mice; Mice, Inbred C57BL; Stress, Psychological; Swimming | 2018 |
Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Disease Models, Animal; Flavonols; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocytes, Smooth Muscle; Pulmonary Artery; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Vascular Remodeling | 2017 |
Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Flavonols; Freund's Adjuvant; Heme Oxygenase (Decyclizing); Liver; Male; Malondialdehyde; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Brain; Cell Line, Transformed; Cognition Disorders; Cytokines; Disease Models, Animal; Encephalitis; Flavonols; Gene Expression Regulation; Humans; Inflammasomes; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mutation; NLR Family, Pyrin Domain-Containing 3 Protein; Presenilin-1; RNA, Messenger; Time Factors | 2018 |
Astragalin and dihydromyricetin as adjuncts to histidine‑tryptophan‑ketoglutarate cardioplegia enhances protection during cardioplegic arrest.
Topics: Animals; Apoptosis; Biomarkers; Cardioplegic Solutions; Cardiotonic Agents; Cytokines; Disease Models, Animal; Flavonols; Glucose; Heart Arrest; Heart Arrest, Induced; Hemodynamics; Inflammation Mediators; Kaempferols; Male; Mannitol; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Potassium Chloride; Procaine; Rats; Recovery of Function; Ventricular Function | 2018 |
Dihydromyricetin from ampelopsis grossedentata protects against vascular neointimal formation via induction of TR3.
Topics: Ampelopsis; Animals; Carotid Arteries; Carotid Stenosis; Cell Line; Cell Proliferation; Disease Models, Animal; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nuclear Receptor Subfamily 4, Group A, Member 1; Rats | 2018 |
Protective role of Dihydromyricetin in Alzheimer's disease rat model associated with activating AMPK/SIRT1 signaling pathway.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Animals; Apoptosis; Cognition; Cytokines; Disease Models, Animal; Flavonols; Gene Expression Regulation; Hippocampus; Injections, Intraperitoneal; Injections, Intraventricular; Male; Maze Learning; Memory; Neurons; Nootropic Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Stereotaxic Techniques | 2019 |
Protective effect of dihydromyricetin revents fatty liver through nuclear factor‑κB/p53/B‑cell lymphoma 2‑associated X protein signaling pathways in a rat model.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Disease Models, Animal; Fatty Liver; Flavonols; Gene Expression Regulation; Humans; Inflammation; Liver; NF-kappa B; Oxidative Stress; Rats; Signal Transduction; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2019 |
MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells.
Topics: Animals; Cell Line; Disease Models, Animal; Doxorubicin; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Flavonols; Glucuronidase; Humans; Kidney; Kidney Diseases; Kidney Tubules; Klotho Proteins; Mice; MicroRNAs; Signal Transduction; Transforming Growth Factor beta1; Ureteral Obstruction | 2019 |
Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonols; Inflammasomes; Male; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Sepsis | 2019 |
Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.
Topics: Animals; Chloride Channels; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Drug Synergism; Flavonols; Humans; Irinotecan; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins | 2019 |
Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anxiety; Cognition Disorders; Disease Models, Animal; Flavonols; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2014 |
Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Carbon Tetrachloride; Caspase Inhibitors; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cytochromes c; Disease Models, Animal; Flavonols; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Liver; Liver Failure, Acute; Liver Regeneration; Male; Mice, Inbred C57BL; Mitochondria, Liver; Protein Kinase Inhibitors; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2015 |
Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model.
Topics: Acute Kidney Injury; Animals; Calcium; Creatinine; Disease Models, Animal; Drug Interactions; Endotoxemia; Flavonols; Hyaluronan Receptors; Kidney; Lipopolysaccharides; Male; Osteopontin; Random Allocation; Rats; Rats, Sprague-Dawley | 2016 |
Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
Topics: Animals; Apoptosis; Autophagy; Caspase 3; Disease Models, Animal; Flavonols; Forkhead Box Protein O3; Liver Diseases; Mice; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Reperfusion Injury | 2016 |
Dihydromyricetin as a novel anti-alcohol intoxication medication.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholic Intoxication; Animals; Disease Models, Animal; Drugs, Chinese Herbal; Female; Flavonols; Male; Pregnancy; Primary Cell Culture; Rats; Rats, Sprague-Dawley | 2012 |
[Effects of dihydromyricetin on tumor necrosis factor and NF-kappaB p65 of RAU rats].
Topics: Animals; Disease Models, Animal; Female; Flavonols; Humans; Macrophages; Male; Mouth Mucosa; Rats; Rats, Sprague-Dawley; Stomatitis, Aphthous; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |